LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | AZD-6482 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 3381 | 4513 | 0.7491 | 0.6544 |
MDA-MB-231 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 497 | 4513 | 0.1102 | -0.2254 |
MDA-MB-231 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1317 | 4513 | 0.2919 | 0.0249 |
MDA-MB-231 | AZD8330 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1359 | 4513 | 0.3011 | 0.0375 |
MDA-MB-231 | Barasertib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1444 | 4513 | 0.3201 | 0.0637 |
MDA-MB-231 | BI-2536 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1091 | 4513 | 0.2418 | -0.0441 |
MDA-MB-231 | BMS345541 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1832 | 4513 | 0.4059 | 0.1819 |
MDA-MB-231 | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 530 | 4513 | 0.1174 | -0.2154 |
MDA-MB-231 | GDC-0980 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1550 | 4513 | 0.3435 | 0.0959 |
MDA-MB-231 | NVP-AEW541 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4489 | 4513 | 0.9946 | 0.9926 |
MDA-MB-231 | SB590885 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 3806 | 4513 | 0.8433 | 0.7842 |
MDA-MB-231 | PIK-93 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 3867 | 4513 | 0.8567 | 0.8027 |
MDA-MB-231 | KIN001-043 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 3354 | 4513 | 0.7432 | 0.6464 |
MDA-MB-231 | Alpelisib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4249 | 4513 | 0.9414 | 0.9193 |
MDA-MB-231 | Luminespib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 796 | 4513 | 0.1764 | -0.1342 |
MDA-MB-231 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 414 | 4513 | 0.0917 | -0.2508 |
MDA-MB-231 | OSI-027 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2665 | 4513 | 0.5906 | 0.4362 |
MDA-MB-231 | XMD11-85h | 3.33 | uM | LJP6 | 72 | hr | 1235 | 3577 | 4513 | 0.7926 | 0.7144 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1018 | 4513 | 0.2256 | -0.0664 |
MDA-MB-231 | WH-4-025 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 880 | 4513 | 0.1951 | -0.1084 |
MDA-MB-231 | WZ-4-145 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2486 | 4513 | 0.5508 | 0.3814 |
MDA-MB-231 | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1180 | 4513 | 0.2615 | -0.0170 |
MDA-MB-231 | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4181 | 4513 | 0.9264 | 0.8986 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1350 | 4513 | 0.2992 | 0.0349 |
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1343 | 4513 | 0.2976 | 0.0328 |